Part,  Chapter, Paragraph

 1   II,     5.  2.  3    |     Southern Europe countries (from 99 to 54 per 100.000), 21%
 2   II,     5.  3.  6    |         that were diagnosed in 1995–99 and followed up to December,
 3   II,     5.  3.  6    |           Data for 1990–94 and 1995–99 showed a survival increase
 4   II,     5.  3.  9    |            adults diagnosed in 1995–99: results of the EUROCARE-4
 5   II,     5.  4.  3    |           between 45% (Ireland) and 99% (Netherlands), with a median
 6   II,     5.  4.  3    |           between 44% (Ireland) and 99% (Netherlands), with a median
 7   II,     5.  4.  3    |           between 45% (Ireland) and 99% (Netherlands), with a median
 8   II,     5.  4.  3    |           between 42% (Finland) and 99% (Netherlands), with a median
 9   II,     5.  5.  1    |           up to 6 years of age(1997-99): Early years of life have
10   II,     5.  5.  2    |             84, 85-89, 90-94 and 95-99).~ ~The study included people
11   II,     5.  5.  2    |             groups up to the age of 99, whereas Ferri et al reported
12   II,     5.  5.  2    |         women separately from 30 to 99 in five year age groups.
13   II,     5.  7.  7    |          Kidney Int Suppl 2005 Dec;(99):S16-S19.~Pontoriero G,
14   II,     5.  9.  4    |             or hay fever RR 1.20 (0.99, 1.45). By 2004 this sex
15   II,     6.  3.  3    |             reported by Ireland (34.99), Sweden (28.96), and the
16   II,     6.  3.  6    | considerably between countries with 99% domestic cases in Czech Republic,
17   II,     9.  1.  2    |             congenital anomaly of 0.99 per 1 000 births (Table
18   II,     9.  5.  6    |    Exploding the myths. WHO/HSC/AHE/99.1. Copenhagen. Available
19  III,    10.  2.  1    |            BAC between 0.8g/l and 0.99 g/L.~There is a relationship
20  III,    10.  2.  1    |         Health Organization, 83: 92-99.~ ~Miller W, Wilbourne P (
21  III,    10.  2.  1    |       Sydney, Australia. Addiction, 99: 1315-1322.~ ~European Monitoring
22  III,    10.  2.  1    |      Journal of Applied Physiology, 99:765–770.~ ~Hunter D (2005):
23  III,    10.  3.  1    |            1995. Eur. J. Cancer 38, 99-166.~Darby S, Hill D, Auvinen
24  III,    10.  4.  2    |    Specifically,~ ~• Directive 2003/99/EC on Zoonoses prescribes
25  III,    10.  4.  2    |            1- 60).~ ~Directive 2003/99/EC on the monitoring of
26  III,    10.  4.  2(29)|                      Directive 2003/99/EC of the European Parliament
27  III,    10.  4.  2    |      collected under directive 2003/99/EC.~ ~EFSA has also been
28  III,    10.  4.  2    |              Whereas Directive 2003/99/EC establishes the monitoring
29  III,    10.  4.  2    |             animal feed~ ~ ~In 1998/99 intake of~dioxins and dioxin-like~
30  III,    10.  4.  2    |          and neurotoxic. In the EU, 99,9% of acrylamide is used
31  III,    10.  4.  2    |          that in all scenarios over 99% of each national population
32  III,    10.  4.  2    |       levels and in most cases over 99.9%. The results suggest
33   IV,    11.  5.  6    |               Recommendation No. R (99) 21 of the Committee of
34   IV,    12. 10        |          with the Council Directive 99/31 concerning the sanitary
35   IV,    12. 10        |          with the E.U Regulation 93/99.~o Common Ministerial Decision
36   IV,    12. 10        |         Greece with the law N. 2716/99 and the national program